{"id":"https://openalex.org/W2072053377","doi":"https://doi.org/10.1007/s12026-007-0003-5","title":"Safety of IGIV therapy and infusion-related adverse events","display_name":"Safety of IGIV therapy and infusion-related adverse events","publication_year":2007,"publication_date":"2007-05-25","ids":{"openalex":"https://openalex.org/W2072053377","doi":"https://doi.org/10.1007/s12026-007-0003-5","mag":"2072053377","pmid":"https://pubmed.ncbi.nlm.nih.gov/17917017"},"language":"en","primary_location":{"id":"doi:10.1007/s12026-007-0003-5","doi":"https://doi.org/10.1007/s12026-007-0003-5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12026-007-0003-5","pdf_url":null,"source":{"id":"https://openalex.org/S70378559","display_name":"Immunologic Research","issn_l":"0257-277X","issn":["0257-277X","1559-0755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunologic Research","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037734477","display_name":"Mark C. Ballow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289499695","display_name":"Women & Children's Hospital of Buffalo","ror":"https://ror.org/00kg66g91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289499695"]},{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark Ballow","raw_affiliation_strings":["Department of Pediatrics, Women and Children's Hospital of Buffalo, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14222, USA. ballow@buffalo.edu","State Univ. of New York at Buffalo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Women and Children's Hospital of Buffalo, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14222, USA. ballow@buffalo.edu","institution_ids":["https://openalex.org/I1289499695","https://openalex.org/I63190737"]},{"raw_affiliation_string":"State Univ. of New York at Buffalo","institution_ids":["https://openalex.org/I63190737"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5037734477"],"corresponding_institution_ids":["https://openalex.org/I1289499695","https://openalex.org/I63190737"],"apc_list":{"value":2890,"currency":"USD","value_usd":2890},"apc_paid":null,"fwci":0.6376,"has_fulltext":false,"cited_by_count":93,"citation_normalized_percentile":{"value":0.54552129,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"38","issue":"1-3","first_page":"122","last_page":"132"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/infusion-related-adverse-events","display_name":"infusion-related adverse events","score":0.8579999804496765},{"id":"https://openalex.org/keywords/primary-immunodeficiency","display_name":"primary immunodeficiency","score":0.8870000243186951},{"id":"https://openalex.org/keywords/viral-safety","display_name":"viral safety","score":0.5740000009536743},{"id":"https://openalex.org/keywords/virus-inactivation","display_name":"virus inactivation","score":0.7829999923706055},{"id":"https://openalex.org/keywords/nucleic-acid-testing","display_name":"nucleic acid testing","score":0.7710000276565552},{"id":"https://openalex.org/keywords/donor-screening","display_name":"donor screening","score":0.8330000042915344},{"id":"https://openalex.org/keywords/x-linked-agammaglobulinemia","display_name":"X-linked agammaglobulinemia","score":0.9520000219345093},{"id":"https://openalex.org/keywords/replacement-therapy","display_name":"replacement therapy","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C79162176","wikidata":"https://www.wikidata.org/wiki/Q5520338","display_name":"Gamma globulin","level":3,"score":0.7527250647544861},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7147513628005981},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6785687208175659},{"id":"https://openalex.org/C2779019163","wikidata":"https://www.wikidata.org/wiki/Q3043160","display_name":"Primary immunodeficiency","level":3,"score":0.6596486568450928},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5670382380485535},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5490158796310425},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36237603425979614},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.30801114439964294}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007153","descriptor_name":"Immunologic Deficiency Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s12026-007-0003-5","doi":"https://doi.org/10.1007/s12026-007-0003-5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12026-007-0003-5","pdf_url":null,"source":{"id":"https://openalex.org/S70378559","display_name":"Immunologic Research","issn_l":"0257-277X","issn":["0257-277X","1559-0755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunologic Research","raw_type":"journal-article"},{"id":"pmid:17917017","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17917017","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunologic research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W36966000","https://openalex.org/W40817544","https://openalex.org/W137430603","https://openalex.org/W198408075","https://openalex.org/W1965431513","https://openalex.org/W1968321205","https://openalex.org/W1973248581","https://openalex.org/W1981585113","https://openalex.org/W1982351864","https://openalex.org/W1997579556","https://openalex.org/W2001816353","https://openalex.org/W2006135740","https://openalex.org/W2015912396","https://openalex.org/W2026228148","https://openalex.org/W2027502308","https://openalex.org/W2048099712","https://openalex.org/W2051067984","https://openalex.org/W2056011660","https://openalex.org/W2056538420","https://openalex.org/W2058605959","https://openalex.org/W2058731890","https://openalex.org/W2073371240","https://openalex.org/W2075077800","https://openalex.org/W2076657480","https://openalex.org/W2077155461","https://openalex.org/W2081401816","https://openalex.org/W2082270646","https://openalex.org/W2082443528","https://openalex.org/W2129611280","https://openalex.org/W2318017958","https://openalex.org/W2338481731","https://openalex.org/W2596543441","https://openalex.org/W2992089985","https://openalex.org/W4246291298","https://openalex.org/W4298281876","https://openalex.org/W6863951927"],"related_works":["https://openalex.org/W2105435463","https://openalex.org/W1964358608","https://openalex.org/W2082443528","https://openalex.org/W4300027925","https://openalex.org/W1519695271","https://openalex.org/W4244721214","https://openalex.org/W2017583496","https://openalex.org/W2041998256","https://openalex.org/W2022311566","https://openalex.org/W2160081911"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
